- Report
- November 2023
- 122 Pages
Europe
From €3072EUR$3,450USD£2,663GBP
- Report
- November 2023
- 119 Pages
North America
From €2627EUR$2,950USD£2,277GBP
- Report
- November 2023
- 190 Pages
Global
From €4408EUR$4,950USD£3,820GBP
- Report
- November 2023
- 381 Pages
Global
€4448EUR$4,995USD£3,855GBP
- Report
- October 2023
- 97 Pages
Global
From €2627EUR$2,950USD£2,277GBP
- Report
- October 2023
- 85 Pages
United States
From €4319EUR$4,850USD£3,743GBP
From €4319EUR$4,850USD£3,743GBP
- Report
- September 2023
- 44 Pages
United Kingdom
From €712EUR$800USD£617GBP
- Report
- August 2023
- 220 Pages
Global
€4092EUR$4,595USD£3,546GBP
- Report
- August 2023
- 180 Pages
Global
From €3339EUR$3,750USD£2,894GBP
- Database
- July 2023
Global
From €321EUR$360USD£278GBP
- Report
- July 2023
- 9 Pages
Global
From €4453EUR$5,000USD£3,859GBP
- Report
- July 2023
- 220 Pages
Global
€4092EUR$4,595USD£3,546GBP
- Report
- July 2023
- 220 Pages
Global
€4092EUR$4,595USD£3,546GBP
- Report
- July 2023
- 221 Pages
Global
From €4007EUR$4,500USD£3,473GBP
- Report
- July 2023
- 223 Pages
Global
From €4007EUR$4,500USD£3,473GBP
- Report
- July 2023
- 80 Pages
Middle East
From €4319EUR$4,850USD£3,743GBP
- Report
- July 2023
- 332 Pages
United States
From €7120EUR$7,995USD£6,170GBP
- Report
- July 2023
- 110 Pages
Global
From €2226EUR$2,500USD£1,929GBP
- Report
- June 2023
- 48 Pages
United States
From €534EUR$600USD£463GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more